Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

ACTAPIN TABLET 5MG [SIN13537P]

Active ingredients: AMLODIPINE BESILATE 6.95 MG EQV AMLODIPINE

View product's general information
Last updated 16 September 2026

Product Info

ACTAPIN TABLET 5MG

[SIN13537P]

Product information

Active Ingredient and Strength

AMLODIPINE BESILATE 6.95 MG EQV AMLODIPINE - 5 MG

Dosage Form

TABLET

Manufacturer and Country

PT ACTAVIS INDONESIA - INDONESIA REP OF

Registration Number

SIN13537P

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

C08CA01

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

Indications

  • Hypertension

  • Chronic Stable angina and/or Prizmetal/variant angina.

Dosing

Posology
Posology and method of administration
The usual starting dose is 5 mg daily. May if necessary be increased to 10 mg daily. It is not necessary to adjust the dose of amlodipine during co-administration of thiazides, beta-blockers or ACE inhibitors (angiotensin-converting enzymes). Normal dosage regimens are recommended. Amlodipine, used at similar doses in elderly and younger patients, is equally well tolerated. The efficacy and safety in children has not been investigated.

Contraindications

Contraindications
Hypersensitivity to dihydropyridines (amlodipine, nifedipine, felodipine, isradipine). Or any of the excipients.
Pregnancy (see Pregnancy and Lactation – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information)
Severe hypertension.